×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Bone Diseases
0.300
Biomarker
CTD_human
Aberrant methylation-induced dysfunction of p16 is associated with osteoblast activation caused by fluoride.
30259626
2019
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Fluoride Poisoning
0.300
Biomarker
CTD_human
These results reveal a regulatory role of p16 gene methylation on osteoblasts activation during the development of skeletal fluorosis .
30259626
2019
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Micronuclei, Chromosome-Defective
0.300
Biomarker
CTD_human
Associations between DNA methylation in DNA damage response-related genes and cytokinesis-block micronucleus cytome index in diesel engine exhaust-exposed workers.
26410583
2016
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Micronuclei, Genotoxicant-Induced
0.300
Biomarker
CTD_human
Associations between DNA methylation in DNA damage response-related genes and cytokinesis-block micronucleus cytome index in diesel engine exhaust-exposed workers.
26410583
2016
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Granulomatous Slack Skin
0.300
Biomarker
CTD_human
Genomic landscape of cutaneous T cell lymphoma.
26192916
2015
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Adrenal Gland Neoplasms
0.300
Biomarker
CTD_human
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
24747643
2014
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Neoplasm Invasiveness
0.300
Biomarker
CTD_human
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.
24495407
2014
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Condition, Preneoplastic
0.300
Biomarker
CTD_human
Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
24991542
2014
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Adrenal Cancer
0.300
Biomarker
CTD_human
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
24747643
2014
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Perineurioma
0.300
Biomarker
CTD_human
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
25240281
2014
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Unipolar Depression
0.300
Biomarker
PSYGENET
We have also quantified the mRNA of six genes previously identified as markers of the biopsychological stress associated with major depression : FOS, DUSP1, OGG1, STMN1, p16(INK4a ) and TERT.
23668904
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Brain Stem Neoplasms
0.300
Biomarker
CTD_human
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
24098593
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Brain Stem Neoplasms, Primary
0.300
Biomarker
CTD_human
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
24098593
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Medullary Neoplasms
0.300
Biomarker
CTD_human
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
24098593
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Mesencephalic Neoplasms
0.300
Biomarker
CTD_human
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
24098593
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Pontine Tumors
0.300
Biomarker
CTD_human
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
24098593
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Peripheral Nervous System Diseases
0.300
Biomarker
CTD_human
Epigenetic modifications of DAPK and p16 genes contribute to arsenic-induced skin lesions and nondermatological health effects.
23872714
2013
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Unipolar Depression
0.300
Biomarker
PSYGENET
Up-regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores.
23185405
2012
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Chromosome Deletion
0.300
Biomarker
CTD_human
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
21526190
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Chromosomal translocation
0.300
Biomarker
CTD_human
Characterization of the unique chromosomal translocation identified loss of p16 and upregulation of MDR-1 at protein level.
21325069
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Chromosomal translocation
0.300
Biomarker
CTD_human
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
21526190
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Trisomy
0.300
Biomarker
CTD_human
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
21526190
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Partial Trisomy
0.300
Biomarker
CTD_human
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
21526190
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
Partial Monosomy
0.300
Biomarker
CTD_human
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
21526190
2011
×
Entrez Id:
1029
Gene Symbol:
CDKN2A
CDKN2A
L2 Acute Lymphoblastic Leukemia
0.300
Biomarker
CTD_human
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
20453839
2010